(+) Dibenzoyl Tartaric Acid

CAS Number: 87-69-4

Molecular Formula: C18H14O8

About (+) Dibenzoyl Tartaric Acid

(+) Dibenzoyl Tartaric Acid (CAS 2743-38-6) serves as a cornerstone chiral resolving agent within the North American API intermediates market, where its ability to perform high-efficiency enantiomeric separation of racemic mixtures demands a 99% pharma-grade purity to minimize downstream processing loss. L-Dibenzoyltar...

(+) Dibenzoyl Tartaric Acid Specifications

CAS Number

87-69-4

Molecular Formula

C18H14O8

Molecular Weight

358.30 g/mol

IUPAC Name

(2R,3R)-2,3-dihydroxybutanedioic acid

Canonical SMILES

O=C(O)[C@@H](O)[C@H](O)C(=O)O

InChI Key

YONLFQNRGZXBBF-KBPBESRZSA-N

InChI

InChI=1S/C18H14O8/c19-15(20)13(25-17(23)11-7-3-1-4-8-11)14(16(21)22)26-18(24)12-9-5-2-6-10-12/h1-10,13-14H,(H,19,20)(H,21,22)/t13-,14-/m0/s1

EINECS Number

241-097-1

HSN No

29181390

CAS Number

87-69-4

Molecular Formula

C18H14O8

Molecular Weight

358.30 g/mol

IUPAC Name

(2R,3R)-2,3-dihydroxybutanedioic acid

Canonical SMILES

O=C(O)[C@@H](O)[C@H](O)C(=O)O

InChI Key

YONLFQNRGZXBBF-KBPBESRZSA-N

InChI

InChI=1S/C18H14O8/c19-15(20)13(25-17(23)11-7-3-1-4-8-11)14(16(21)22)26-18(24)12-9-5-2-6-10-12/h1-10,13-14H,(H,19,20)(H,21,22)/t13-,14-/m0/s1

EINECS Number

241-097-1

HSN No

29181390

Molecular Weight

358.30 g/mol

Melting Point

152.0 to 156.0 °C

Boiling Point

606.6ºC at 760mmHg

Precautionary Statement Codes

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501

Hazard Classes and Categories

Skin Irrit. 2 (11.1%) Eye Irrit. 2 (88.9%)

Chiral Resolution

An optically active resolving agent used for separating enantiomers of racemic mixtures, particularly racemic amines and bases, to achieve high chiral purity in the pharmaceutical and fine chemical industries

Asymmetric Synthesis

A chiral auxiliary and ligand employed in stereoselective organic synthesis to facilitate the creation of specific molecular configurations required for drug development

Pharmaceutical Industry

A pharmaceutical intermediate compound applied in the preparation of active pharmaceutical ingredients, including anticancer drugs such as Sotorasib and Zanubrutinib